Background Wide-ranging prevalence estimates of psoriatic arthritis (PsA) in patients with
psoriasis have been reported. Objectives To assess the prevalence and incidence of PsA in …

To inform the WHO Global report on psoriasis, a new comprehensive worldwide systematic
review of the epidemiology of psoriasis was undertaken. The aim of this study was to …

Importance Determining psoriasis prevalence is fundamental to understanding the burden of
the disease, the populations most affected, and health policies to address the disease …

At the beginning of the COVID-19 pandemic, patients with immune-mediated inflammatory
diseases were considered to be at high risk for SARS-CoV-2 infection and the development …

Background: Psoriasis is an autoimmune disease that ingeminates itself with the repeated
proliferation of keratinocytes. It globally strikes a 2-5% population on an average …

Psoriasis is an inflammatory disease of the epidermis based on an immunological
mechanism involving Langerhans cells and T lymphocytes that produce pro-inflammatory …

Psoriasis is a chronic inflammatory disease that affects approximately 7.5 million people in
the United States. The disease results in significant suffering, morbidity, and economic …

Background Psoriasis is a very prevalent systemic chronic inflammatory disease. Major
cardiovascular events are the main cause of mortality in these patients which suggests an …

Racial and ethnic disparities in dermatology negatively affect outcomes such as mortality
and quality of life. Dermatologists and dermatologic surgeons should be familiar with …

Background Studies indicate adherence to biologics among patients with psoriasis is low,
yet little is known about their use in the Medicare population. Objective We sought to …